130 related articles for article (PubMed ID: 6300247)
1. In vitro growth of B lymphocytes infiltrating human melanoma tissue by transformation with EBV: evidence for secretion of anti-melanoma antibodies by some transformed cells.
Watson DB; Burns GF; Mackay IR
J Immunol; 1983 May; 130(5):2442-7. PubMed ID: 6300247
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of EBV-transformable human B lymphocyte populations.
Chan MA; Stein LD; Dosch HM; Sigal NH
J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
[TBL] [Abstract][Full Text] [Related]
3. Establishment of specific antibody producing human lines by antigen preselection and Epstein-Barr virus (EBV)-transformation.
Steinitz M; Koskimies S; Klein G; Mäkelä O
J Clin Lab Immunol; 1979 Apr; 2(1):1-7. PubMed ID: 95800
[TBL] [Abstract][Full Text] [Related]
4. A human monoclonal antimelanoma single-chain Fv antibody derived from tumor-infiltrating lymphocytes.
Zhang H; Lake DF; Barbuto JA; Bernstein RM; Grimes WJ; Hersh EM
Cancer Res; 1995 Aug; 55(16):3584-91. PubMed ID: 7627967
[TBL] [Abstract][Full Text] [Related]
5. In vitro regulation of IgA subclass production. III. Selective transformation of IgA1 producing cells by Epstein-Barr virus.
Conley ME; Chan MA; Sigal NH
J Immunol; 1987 Mar; 138(5):1403-7. PubMed ID: 3027178
[TBL] [Abstract][Full Text] [Related]
6. Production of anti-endothelial cell antibodies by coculture of EBV-infected human B cells with endothelial cells.
Delneste Y; Lassalle P; Jeannin P; Mannessier L; Dessaint JP; Joseph M; Tonnel AB
Cell Immunol; 1993 Aug; 150(1):15-26. PubMed ID: 7688268
[TBL] [Abstract][Full Text] [Related]
7. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines.
Mevissen ML; Kwekkeboom J; Goormachtig E; Lindhout E; de Groot C
Hum Antibodies Hybridomas; 1993 Apr; 4(2):66-73. PubMed ID: 8390865
[TBL] [Abstract][Full Text] [Related]
8. In vitro immunization of human B lymphocytes with cultured melanoma cells (SK-MEL 28).
Zhang XM; Borrebaeck CA
Hum Antibodies Hybridomas; 1990; 1(1):42-6. PubMed ID: 1966473
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal anti-parasite and anti-RBC antibodies produced by stable EBV-transformed B cell lines from malaria patients.
Lundgren K; Wahlgren M; Troye-Blomberg M; Berzins K; Perlmann H; Perlmann P
J Immunol; 1983 Oct; 131(4):2000-3. PubMed ID: 6311902
[TBL] [Abstract][Full Text] [Related]
10. Induction of antibody-producing cell lines by Epstein-Barr virus.
Viallat JR; Kourilsky FM
Pathol Biol (Paris); 1982 Apr; 30(4):232-42. PubMed ID: 6283460
[TBL] [Abstract][Full Text] [Related]
11. [Preparation of human monoclonal antibodies reactive with human melanoma and the possibility of clinical application].
Yamaguchi H
Gan To Kagaku Ryoho; 1988 May; 15(5):1677-84. PubMed ID: 2835935
[TBL] [Abstract][Full Text] [Related]
12. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
13. Immunoregulatory human T lymphocytes triggered as a consequence of viral infection: clonal analysis of helper, suppressor inducer and suppressor effector cell populations.
Meuer SC; Cooper DA; Hodgdon JC; Hussey RE; Morimoto C; Schlossman SF; Reinherz EL
J Immunol; 1983 Sep; 131(3):1167-72. PubMed ID: 6309959
[TBL] [Abstract][Full Text] [Related]
14. Further characterization of IgM antibodies against maternal alloreactive T cells produced by cloned Epstein Barr virus-transformed cord B cells.
Miyagawa Y
J Immunol; 1984 Sep; 133(3):1270-7. PubMed ID: 6086753
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
[TBL] [Abstract][Full Text] [Related]
16. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA
Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
[TBL] [Abstract][Full Text] [Related]
17. [Human antibodies to cedar pollen secreted by human peripheral lymphocytes transformed by Epstein-Barr virus].
Shinmoto H; Takahashi T; Shinmoto M
Arerugi; 2004 Jan; 53(1):14-8. PubMed ID: 14762326
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow-derived lymphoid cell lines from patients with agammaglobulinemia.
Schwaber J; Lazarus H; Rosen FS
J Clin Invest; 1978 Aug; 62(2):302-10. PubMed ID: 209061
[TBL] [Abstract][Full Text] [Related]
19. Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells.
Herlyn M; Clark WH; Mastrangelo MJ; Guerry DP; Elder DE; LaRossa D; Hamilton R; Bondi E; Tuthill R; Steplewski Z; Koprowski H
Cancer Res; 1980 Oct; 40(10):3602-9. PubMed ID: 6159966
[TBL] [Abstract][Full Text] [Related]
20. Specificity and isotype of Rh specific antibodies produced by human B-cell lines established from alloimmunized Rh negative women.
Pasha RP; Bahrami ZS; Niroomanesh S; Ramzi F; Razavi AR; Shokri F
Transfus Apher Sci; 2005 Oct; 33(2):119-27. PubMed ID: 16103012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
